Remote Blood-Draw Dried-Spot Device Market Trends And Growth Outlook Across The 2026–2030 Forecast Period
The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Is The Remote Blood-Draw Dried-Spot Device Market’s Market Value Anticipated To Evolve From 2026 To 2030?
The market size for remote blood-draw dried-spot devices has experienced rapid expansion in recent years. This market is projected to expand from $0.92 billion in 2025 to $1.05 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.5%. Historically, this expansion has been driven by factors such as the rise in remote diagnostics, the demand for greater patient convenience, the broadening of lab testing services, the implementation of newborn screening programs, and the general increase in telemedicine.
The market size for remote blood-draw dried-spot devices is poised for substantial expansion over the next few years. This sector is projected to reach $1.73 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.2%. This projected increase can be attributed to the broadening of home healthcare services, the ongoing need for chronic disease monitoring, advancements in digital pathology, enhanced logistics optimization, and improvements in population health management. Significant trends expected during this period involve the rise of at-home blood sample collection, the growth of mail-in diagnostic testing, the development of minimally invasive sampling devices, the adoption of microfluidic blood collection techniques, and the shift towards decentralized diagnostic testing.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29173&type=smp
Which Strategic Drivers Are Supporting The Remote Blood-Draw Dried-Spot Device Market Development?
The expanding focus on personalized medicine is anticipated to drive the advancement of the remote blood-draw dried-spot device market in the future. Personalized medicine involves customizing healthcare and preventive measures based on an individual’s unique genetic, molecular, and clinical profile to achieve the best possible results. The uptake of personalized medicine is growing because genomic progress facilitates the accurate detection of genetic variations influencing disease susceptibility and response to treatment, leading to more potent and specific therapies. Remote blood-draw dried-spot devices support personalized medicine by offering a simple, home-based method for collecting small blood samples, which permits regular tracking of biomarkers and genetic data to inform customized treatment and therapeutic choices. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA granted approval to 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022. The personalized treatments given approval in 2023 also comprised seven cancer drugs and three for other illnesses and conditions. Consequently, the rising emphasis on personalized medicine is propelling the expansion of the remote blood-draw dried-spot device market.
What Are The Core Segment Classifications In The Remote Blood-Draw Dried-Spot Device Market?
The remote blood-draw dried-spot device market covered in this report is segmented –
1) By Product Type: Filter Paper Devices, Microfluidic Devices, Other Product Types
2) By Sample Type: Whole Blood, Plasma, Serum, Other Sample Types
3) By Distribution Channel: Direct Sales, Online Retail, Pharmacies, Other Distribution Channels
4) By Application: Disease Diagnosis, Therapeutic Drug Monitoring, Newborn Screening, Forensic Testing, Other Applications
5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Home Care Settings, Other End-Users
Subsegments:
1) By Filter Paper Devices: Whole Blood Collection Cards, Plasma Separation Cards
2) By Microfluidic Devices: Integrated Microchannel Systems, Capillary-Driven Microfluidic Chips
3) By Other Product Types: Volumetric Absorptive Micro sampling Devices, Capillary Blood Collection Tubes
Which Trends Are Influencing The Expansion Of The Remote Blood-Draw Dried-Spot Device Market?
Leading companies in the remote blood-draw dried-spot device market are concentrating on developing advanced strategies, such as decentralized sampling, to facilitate at-home or distant blood collection, enhance patient convenience, and boost clinical trial efficiency. Decentralized sampling involves acquiring biological specimens at sites convenient for individuals, as opposed to traditional central laboratories or clinics, thereby enabling wider accessibility, quicker collection, and more adaptable involvement in healthcare or research initiatives. For instance, in March 2025, Tasso Inc., a US-based healthcare technology company, introduced a next-generation technology for dried blood spot (DBS) sample collection, primarily intended for clinical trials and sports anti-doping testing. This innovation offers a virtually painless, convenient, and precise method for blood sampling, making it highly suitable for clinical studies and anti-doping examinations in sports. Utilizing a patient-friendly device, it provides accurate volumetric blood samples, leading to better compliance and enabling remote collection. By simplifying the sampling procedure, lowering participation barriers, and generating high-quality quantitative data, it contributes to faster drug development and reinforces decentralized testing models.
Which Companies Are Engaged In The Remote Blood-Draw Dried-Spot Device Market Environment?
Major companies operating in the remote blood-draw dried-spot device market are Neoteryx Inc., DBS System SA, Tasso Inc., Capitainer AB, Spot On Sciences Inc., HemaXis S.A., Drawbridge Health Inc., RDA Spot Inc., YourBio Health Inc., Lipomic Healthcare Inc., Trajan Scientific and Medical Pty Ltd., Salimetrics LLC, Eastern Business Forms Inc., PanoHealth Inc., RedDrop Dx Inc., Nanowear Inc., Bioanalytical Systems Inc., Phenomenex Inc., Greiner Bio-One International GmbH, Whatman (Cytiva)
Access The Complete Remote Blood-Draw Dried-Spot Device Market Report:
Which Region Has The Strongest Presence In The Remote Blood-Draw Dried-Spot Device Market?
North America was the largest region in the remote blood-draw dried-spot device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the remote blood-draw dried-spot device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Remote Blood-Draw Dried-Spot Device Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Remote Blood-Draw Dried-Spot Device Market 2026, By The Business Research Company
Blood Processing Devices And Consumables Market Report 2026
Blood Collection Processing Management Devices Market Report 2026
Capillary Blood Collection Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
